ArticleChemical & biomedical imaging2025
Tuning SBDs as Endoplasmic Reticulum Self-Targeting Fluorophores and Its Application for Zn
Article in Chemical & biomedical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Endogenous Albumin-Mediated Disassembly of Phthalocyanine Nanoparticles for Tumor-Selective Imaging and Sonodynamic Therapy.Chemical & biomedical imaging · 2026Article
- Potent Fluorescent Probe for Target-Engagement Studies of Allosteric Pyruvate Kinase Modulators.Angewandte Chemie (International ed. in English) · 2025Article
- Bright Zinc Probes with Thiomorpholine Monoxide Auxochromes for Imaging Insulin Secretion.Chemical & biomedical imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emerging endoplasmic recticulum (ER) crosstalk system demands a more reliable approach for ER-targeting fluorophores to explore ER-associated biochemical species and events. Providing the aromatic sulfonamides' affinity to ATP-sensitive potassium channel protein localized mainly on ER membrane, the sulfonamide fluorophore 4-amino-7-sulfamoylbenzoxadiazole (SBD) was modified to construct ER self-targeting fluorophores without any additional targeting group by alternating the N-substituent structure and numbers of its 4-amino and 7-sulfamoyl groups. The results revealed that a ClogP value over 3.0 endowed those SBDs the ER self-targetability effectively. This provides a strategy to devise an ER-targeting probe by simply modifying the 4-amino group of SBDs as a sensing moiety to make the probe CLogP over 3.0 despite the CLogP value of parent SBDs, and two ER-targeting Zn
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.